Back to BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP

ELVNELVN
10 quarters

Position history for BAKER BROS. ADVISORS LPBAKER BROS. ADVISORS LP's holdings in ENLIVEN THERAPEUTICS INC

BAKER BROS. ADVISORS LP holds 905,191 shares of ELVN (ENLIVEN THERAPEUTICS INC), worth $45.9M as of 2026-Q2. ELVN represents 0.2% of BAKER BROS. ADVISORS LP's portfolio.

Current Value

$45.9M

Current Shares

905,191

Total Value Change

+$43.9M

Total Shares Change

+790,358

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
905,191
0.0%
$45.9M0.2%$50.75
0
2026-Q1
Increased
905,191
+233.5%
$35.5M0.2%$28.75
56
2025-Q4
Increased
271,406
+136.3%
$4.2M0.0%$15.55
43
2025-Q3
Unchanged
114,833
0.0%
$2.4M0.0%$20.30
0
2025-Q2
Unchanged
114,833
0.0%
$2.3M0.0%$20.68
0
2025-Q1
Unchanged
114,833
0.0%
$2.3M0.0%$21.07
0
2024-Q4
Unchanged
114,833
0.0%
$2.6M0.0%$22.39
0
2024-Q3
Unchanged
114,833
0.0%
$2.9M0.0%$24.13
0
2024-Q2
Unchanged
114,833
0.0%
$2.7M0.0%$23.37
0
2024-Q1
New
114,833
-
$2M0.0%$17.59
36

Other major holders of ELVN: FMR LLC, Polar Capital Holdings Plc, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used